Liminatus Pharma, Inc.
LIMN· Nasdaq
Liminatus Pharma, Inc.
- Last sale
- Oct 2, 2026 · +5.42%
- Market cap
- $261.25M
- 67.16M shares
- Filings
- 108
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | $2,685,334 | reported |
Liminatus Pharma, Inc. · CIK 1971387 · Engraved from SEC EDGAR
